New study aims to find safe fasting time for diabetics on Weight-Loss drugs before surgery

NCT ID NCT07506356

Recruiting now Knowledge-focused Sponsor: University Hospital, Geneva Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how long people with type 2 diabetes need to stop taking GLP-1 medications (like semaglutide) before surgery to make sure their stomach is empty. These drugs slow down digestion, which can increase the risk of food or liquid entering the lungs during anesthesia. Researchers will use ultrasound to measure stomach volume in 38 participants after a 6-hour fast, 7 days after their last injection. The goal is to find a safe waiting period for surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETE TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus gastroesophageal reflux disease type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETE TYPE 2 PULMONARY ASPIRATION DURING ANAESTHETIC INDUCTION REGURGITATION

Contacts and locations

Show contact details

Locations

Hôpitaux Universitaires de Genève
RECRUITING

Geneva, Canton of Geneva, 1211, Switzerland

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact